title: Heptahelical and other G-protein-coupled receptors (GPCRs) signaling.
abstract: Heptahelical receptors are coupled to heterotrimeric GTP-binding proteins (G-proteins) which transduce most signals through their alpha and betagamma subunits to effectors, enzymes and ion channels. Of the 367 heptahelical receptors for endogenous ligands, about 330 are potential targets for drug discovery with agonist, antagonist or inverse agonist properties. The term G-protein-coupled receptors (GPCRs) is a broader functional definition rather than a structural one referring to heptahelical receptors specifically. Non-heptahelical putative GPCRs include some transmembrane receptors with tyrosine-kinase activity on their cytosolic endings (EGF, insulin and IGF-1 receptors), other transmembrane receptors (mannose-6-phosphate/IGF-2 receptor and integrin-associated protein IAP or CD47), and some receptors belonging to the class of glycosylphosphatidylinositol (GPI)-anchored proteins and located on the outer face of the plasma membrane. Also, activators of G-protein signaling (AGS) proteins that regulate vesicular trafficking activate heterotrimeric G-proteins in the Golgi independently of receptor activation. Main effectors activated through their direct interactions with alpha subunits or betagamma dimers of heterotrimeric G-proteins include adenylylcyclases, cGMP-phosphodiesterase, phospholipases Cbeta, phosphoinositide 3-kinase gamma, Ca(V2) calcium channels, GIRK/Kir3 potassium channels, and guanine nucleotide exchange factors RasGEF and RhoGEF leading to small G-proteins and MAP-kinases activation. Current signaling cascades leading to final cell responses are depicted.
authors.affiliation: Laboratoire de signalisation cellulaire,CNRS UMR 7175-LC1, Faculté de Pharmacie, Université Louis Pasteur--rasbourg 1, BP24, 67401 Illkirch Cedex, France. landry@pharma.u-strasbg.fr
authors.forename: Y
authors.initials: Y
authors.lastname: Landry
authors.forename: N
authors.initials: N
authors.lastname: Niederhoffer
authors.forename: E
authors.initials: E
authors.lastname: Sick
authors.forename: J P
authors.initials: JP
authors.lastname: Gies
mesh_terms: D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D015195:Drug Design; D004789:Enzyme Activation; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels / Q000187:drug effects / Q000378:metabolism; D020662:Guanine Nucleotide Exchange Factors / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D019869:Phosphatidylinositol 3-Kinases / Q000187:drug effects / Q000378:metabolism; D010740:Phospholipases / Q000187:drug effects / Q000378:metabolism; D010727:Phosphoric Diester Hydrolases / Q000187:drug effects / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction; D014118:Toxins, Biological / Q000494:pharmacology
chemical_list: D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D020662:Guanine Nucleotide Exchange Factors; D043562:Receptors, G-Protein-Coupled; D014118:Toxins, Biological; D019869:Phosphatidylinositol 3-Kinases; D010740:Phospholipases; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP